Search terms

University Medical Center Utrecht is first hospital to expand diagnostic capabilities in daily practice with Philips IQon Spectral CT System

Spectral detector-based CT receives CE mark for diagnostic use

May 4, 2016

Amsterdam, The Netherlands – Royal Philips (NYSE:PHG, AEX:PHIA) today announced the installation of its IQon Spectral CT, the industry’s first spectral detector-based Computed Tomography (CT) at the University Medical Center Utrecht (UMC Utrecht). The Philips IQon Spectral CT provides multiple layers of retrospective, diagnostic data in a single, low-dose scan with seamless integration into existing hospital system protocols. It can provide sufficient information with only one scan to help clinicians make fast, confident diagnoses, driving improved clinical and economic outcomes. This installation builds on UMC Utrecht’s ongoing commitment to selecting innovative solutions designed to improve patient care. This is the first IQon installation in the world following recent CE marking for diagnostic use.

Offering high-image quality, the IQon Spectral CT allows clinicians to uncover critical information to help inform fast diagnosis and treatment even in the most challenging cases.

“Unlike traditional CT images, which can be limited in structural detail and require additional scans, Philips’ IQon Spectral CT allows our clinicians to identify the composition of materials in the body in one scan,” said Prof. Tim Leiner, Imaging Division, UMC Utrecht.“In a patient-focused care environment, comprehensive solutions that enable ‘first-time right’ testing and diagnostics without compromises can be revolutionary in addressing many of our greatest challenges, including workflow and patient satisfaction.”

“In healthcare environments where providers are challenged with increasing throughput and quality, while reducing waste, advancements in CT technology that allow for quick, confident diagnosis make a significant difference – for providers and patients,” said Henk Valk, General Manager, Philips Benelux. “Providing more data and high-quality images in a single scan delivers on Philips and UMC Utrecht’s shared goal to improve patient care, while also addressing some of the biggest issues facing providers and affecting patients.”

Philips IQon Spectral CT is currently available for sale in 36 countries. To learn more about IQon Spectral CT and the full suite of Philips’ innovative CT solutions, please visit: SpectralCTLearningCenter.philips.com.

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. The company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips’ wholly owned subsidiary Philips Lighting is the global leader in lighting products, systems and services. Headquartered in the Netherlands, Philips posted 2015 sales of EUR 24.2 billion and employs approximately 104,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

About UMC Utrecht

University Medical Center Utrecht (UMC Utrecht) belongs to the largest public healthcare institutions in the Netherlands. It was created in 2000 through the merger of Utrecht Academic Hospital, Wilhelmina Children’s Hospital and the Medical Faculty of Utrecht University. UMC Utrecht has the ambition to be a leading international healthcare provider, medical school and research institute that is exciting for its people, attractive to talent and embodies a culture of teamwork, innovation, sustainability and a competitive spirit. As a patient-centered organization, its 11,000 employees are dedicated to prevent disease, improve healthcare, develop new treatment methods and refine existing ones, with patient safety and quality as cornerstones. Strategic research programs are Brain, Child Health, Circulatory Health, Infection & Immunity, Personalized Cancer Care and Regenerative Medicine & Stem Cells. UMC Utrecht is embedded in a vibrant and entrepreneurial science community where knowledge about health. disease and healthcare is generated, validated, shared and applied. For more information, visit http://www.umcutrecht.nl/nl/.